• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖化角度看糖尿病血管病变:病因与治疗。

A Glycation Angle to Look into the Diabetic Vasculopathy: Cause and Cure.

机构信息

Laboratory of Glycation Biology and Metabolic Disorders, IIRC-1, Integral University, Lucknow, U.P.. India.

Department of Bio-sciences, Integral University, Lucknow , UP. India.

出版信息

Curr Vasc Pharmacol. 2017;15(4):352-364. doi: 10.2174/1570161115666170327162639.

DOI:10.2174/1570161115666170327162639
PMID:28356033
Abstract

In diabetic patients, accelerated glycation process causes increased oxidative stress and chronic hyperglycaemia that play a vital role in the diabetic complications. Extensive intracellular and extracellular generation of these glycated products finally form advanced glycation end products (AGEs). The accumulation of AGEs is related with the intensive risk for microvascular and macrovascular injuries for diabetic patients. Therefore, formation of AGEs results from the condensation of reducing sugars with biomolecules like nucleic acids, proteins, and lipids which potentially alter their function. Effect of AGEs formation is also related with the cross-linking that promotes vascular stiffness which modifies the vascular structure and long-life function of proteins. Formation of AGEs may also activate specific receptors, like receptor for AGEs (RAGEs) that induce the intracellular signaling which enhance the oxidative stress and also the amplification of key pro-sclerotic and pro-inflammatory cytokines. From last few decades, a huge number of pre-clinical studies related with the AGEs formation in the diabetic patients have been performed. The target for such trials was the formation and degradation of AGEs, and its interaction with RAGEs. This review focuses on the mechanism how these AGEs exert detrimental nuisance in the diabetes, as well as deal with existing strategies to disrupt the action or formation of AGEs. Therefore, the unseen role of both the early and advanced stage glycation in the diabetic Vasculopathy is described. We have also illustrated how the glycation inhibition results in the delay of the development of vascular complications in diabetic patients.

摘要

在糖尿病患者中,糖化过程加速导致氧化应激增加和慢性高血糖,这在糖尿病并发症中起着至关重要的作用。这些糖化产物在细胞内和细胞外的广泛产生最终形成晚期糖基化终末产物(AGEs)。AGEs 的积累与糖尿病患者微血管和大血管损伤的高风险密切相关。因此,AGEs 的形成是由于还原糖与核酸、蛋白质和脂质等生物分子的缩合,这些生物分子的功能可能会发生改变。AGEs 形成的影响也与促进血管僵硬的交联有关,交联会改变血管结构和蛋白质的长寿命功能。AGEs 的形成也可能激活特定的受体,如 AGEs 受体(RAGEs),诱导细胞内信号增强氧化应激,放大关键的促硬化和促炎细胞因子。在过去的几十年中,已经进行了大量与糖尿病患者 AGEs 形成相关的临床前研究。这些试验的目的是 AGEs 的形成和降解,以及它与 RAGEs 的相互作用。这篇综述重点介绍了这些 AGEs 在糖尿病中产生有害影响的机制,以及现有的破坏 AGEs 作用或形成的策略。因此,描述了早期和晚期糖基化在糖尿病血管病变中的未知作用。我们还说明了糖基化抑制如何导致糖尿病患者血管并发症的发展延迟。

相似文献

1
A Glycation Angle to Look into the Diabetic Vasculopathy: Cause and Cure.糖化角度看糖尿病血管病变:病因与治疗。
Curr Vasc Pharmacol. 2017;15(4):352-364. doi: 10.2174/1570161115666170327162639.
2
Advanced Glycation End Products: A Molecular Target for Vascular Complications in Diabetes.晚期糖基化终末产物:糖尿病血管并发症的分子靶点
Mol Med. 2015 Oct 27;21 Suppl 1(Suppl 1):S32-40. doi: 10.2119/molmed.2015.00067.
3
The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus.晚期糖基化终产物受体在介导晚期糖基化终产物对糖尿病血管疾病发展的影响中起核心作用。
Nephrol Dial Transplant. 1996;11 Suppl 5:13-6. doi: 10.1093/ndt/11.supp5.13.
4
Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications.晚期糖基化终末产物(AGEs)-受体RAGE轴与二肽基肽酶-4-肠促胰岛素系统在糖尿病血管并发症中的相互作用
Cardiovasc Diabetol. 2015 Jan 13;14:2. doi: 10.1186/s12933-015-0176-5.
5
Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and mitochondrial functions.晚期糖基化终产物(AGEs)及其受体(RAGE)对心肌收缩和线粒体功能的影响。
Glycoconj J. 2016 Aug;33(4):607-17. doi: 10.1007/s10719-016-9679-x. Epub 2016 Jun 8.
6
Receptor for advanced glycation end products (RAGE): a novel therapeutic target for diabetic vascular complication.晚期糖基化终末产物受体(RAGE):糖尿病血管并发症的新型治疗靶点。
Curr Pharm Des. 2008;14(5):487-95. doi: 10.2174/138161208783597416.
7
Involvement of the toxic AGEs (TAGE)-RAGE system in the pathogenesis of diabetic vascular complications: a novel therapeutic strategy.AGEs(晚期糖基化终末产物)-RAGE 系统在糖尿病血管并发症发病机制中的作用:一种新的治疗策略。
Curr Drug Targets. 2010 Nov;11(11):1468-82. doi: 10.2174/1389450111009011468.
8
Clinical review: The role of advanced glycation end products in progression and complications of diabetes.临床综述:晚期糖基化终末产物在糖尿病进展及并发症中的作用
J Clin Endocrinol Metab. 2008 Apr;93(4):1143-52. doi: 10.1210/jc.2007-1817. Epub 2008 Jan 8.
9
Agents that block advanced glycation end product (AGE)-RAGE (receptor for AGEs)-oxidative stress system: a novel therapeutic strategy for diabetic vascular complications.阻断晚期糖基化终末产物(AGE)-RAGE(AGE受体)-氧化应激系统的药物:糖尿病血管并发症的一种新型治疗策略。
Expert Opin Investig Drugs. 2008 Jul;17(7):983-96. doi: 10.1517/13543784.17.7.983.
10
Potential role of HMG CoA reductase inhibitor on oxidative stress induced by advanced glycation endproducts in vascular smooth muscle cells of diabetic vasculopathy.羟甲基戊二酰辅酶 A 还原酶抑制剂在糖尿病血管病变血管平滑肌细胞糖基化终产物诱导的氧化应激中的潜在作用。
Exp Mol Med. 2009 Nov 30;41(11):802-11. doi: 10.3858/emm.2009.41.11.086.

引用本文的文献

1
Extracellular matrix in vascular homeostasis and disease.血管稳态与疾病中的细胞外基质
Nat Rev Cardiol. 2025 May;22(5):333-353. doi: 10.1038/s41569-024-01103-0. Epub 2025 Jan 2.
2
Molecular Basis for the Involvement of Mammalian Serum Albumin in the AGE/RAGE Axis: A Comprehensive Computational Study.哺乳动物血清白蛋白参与 AGE/RAGE 轴的分子基础:全面的计算研究。
Int J Mol Sci. 2024 Mar 11;25(6):3204. doi: 10.3390/ijms25063204.
3
Unveiling the pathogenesis and therapeutic approaches for diabetic nephropathy: insights from panvascular diseases.
揭示糖尿病肾病的发病机制和治疗方法:泛血管疾病的启示。
Front Endocrinol (Lausanne). 2024 Feb 22;15:1368481. doi: 10.3389/fendo.2024.1368481. eCollection 2024.
4
Protective effects of catalpol on cardio-cerebrovascular diseases: A comprehensive review.梓醇对心脑血管疾病的保护作用:综述
J Pharm Anal. 2023 Oct;13(10):1089-1101. doi: 10.1016/j.jpha.2023.06.010. Epub 2023 Jun 21.
5
SGLT2 Inhibitors in Aging-Related Cardiovascular Disease: A Review of Potential Mechanisms.SGLT2 抑制剂在与衰老相关的心血管疾病中的作用:潜在机制的综述。
Am J Cardiovasc Drugs. 2023 Nov;23(6):641-662. doi: 10.1007/s40256-023-00602-8. Epub 2023 Aug 24.
6
Elicitation of Inhibitory Effects for AGE-Induced Oxidative Stress in Rotator Cuff-Derived Cells by Apocynin.载脂蛋白对肩袖衍生细胞中晚期糖基化终产物诱导的氧化应激的抑制作用激发
Curr Issues Mol Biol. 2023 Apr 14;45(4):3434-3445. doi: 10.3390/cimb45040225.
7
Low Level of Advanced Glycation End Products in Serum of Patients with Allergic Rhinitis and Chronic Epstein-Barr Virus Infection at Different Stages of Virus Persistence.不同病毒持续阶段的变应性鼻炎和慢性EB病毒感染患者血清中晚期糖基化终末产物水平较低
J Immunol Res. 2022 Nov 11;2022:4363927. doi: 10.1155/2022/4363927. eCollection 2022.
8
Selected Plant-Derived Polyphenols as Potential Therapeutic Agents for Peripheral Artery Disease: Molecular Mechanisms, Efficacy and Safety.部分植物来源的多酚类化合物作为外周动脉疾病的潜在治疗药物:分子机制、疗效和安全性。
Molecules. 2022 Oct 21;27(20):7110. doi: 10.3390/molecules27207110.
9
Inhibitory Effects of Myriocin on Non-Enzymatic Glycation of Bovine Serum Albumin.美罗昔康对牛血清白蛋白非酶糖基化的抑制作用。
Molecules. 2022 Oct 18;27(20):6995. doi: 10.3390/molecules27206995.
10
Impact of the Rapid Normalization of Chronic Hyperglycemia on the Receptor Activator of Nuclear Factor-Kappa B Ligand and the Osteoprotegerin System in Patients Living with Type 2 Diabetes: RANKL-GLYC Study.慢性高血糖快速正常化对 2 型糖尿病患者核因子-κB 受体激活物配体和骨保护素系统的影响:RANKL-GLYC 研究。
Medicina (Kaunas). 2022 Apr 18;58(4):555. doi: 10.3390/medicina58040555.